Trial Profile
To assess platelet aggregation in patients treated with dabigatran.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2017
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Embolism and thrombosis
- Focus Therapeutic Use
- 14 Jan 2017 New trial record
- 06 Dec 2016 Results presented at the 58th Annual Meeting and Exposition of the American Society of Hematology